2-(苯基硫)喹啉 | 22190-12-1

• 物质功能分类: 医药中间体 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 2-(苯基硫)喹啉
• 英文名称: 2-phenylsulfanyl-quinoline
• 英文别名: 2-Quinolyl phenyl sulfide；2-phenylsulfanylquinoline；2-(phenylthio)quinoline；2-phenylthioquinoline；2-Phenylmercapto-chinolin
• CAS: 22190-12-1
• 化学式: C₁₅H₁₁NS
• 分子量: 237.325
• InChiKey: BCOSVBKPHCKEII-UHFFFAOYSA-N

物化性质

• 熔点：
  48 °C
• 沸点：
  164-166 °C(Press: 0.6 Torr)
• 密度：
  1.1568 (rough estimate)
• 稳定性/保质期：

  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 安全说明：
  S24/25

SDS

Name:	2-(Phenylthio)quinoline 98% (gc) Material Safety Data Sheet
Synonym:	Quinoline,2(phenylthio)
CAS:	22190-12-1

Section 1 - Chemical Product MSDS Name:2-(Phenylthio)quinoline 98% (gc) Material Safety Data Sheet
Synonym:Quinoline,2(phenylthio)

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
22190-12-1	Quinoline, 2-(phenylthio)-	98.0	244-828-2

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Antidote: None reported.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 22190-12-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 48 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H11NS
Molecular Weight: 237.33

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 22190-12-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Quinoline, 2-(phenylthio)- - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 22190-12-1: No information available.
Canada
CAS# 22190-12-1 is listed on Canada's NDSL List.
CAS# 22190-12-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 22190-12-1 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(苯基硫)喹啉 在 sodium hypochlorite 、 溶剂黄146 作用下， 反应 2.0h， 以7.08 g的产率得到2-(苯磺酰基)喹啉
  参考文献：
  名称：

  Green Chemical Synthesis of 2-Benzenesulfonyl-pyridine and Related Derivatives

  摘要：

  A practical synthesis of 2-benzenesulfonylpyridine, 1, is described which is a key starting material for the manufacture of an investigational new drug candidate at Eli Lilly and Company. An optimized green chemical process was developed which features a novel tandem SNAr/oxidation under mild conditions to produce the target sulfone, 1, in 86% yield and >99% purity. In addition, this novel, environmentally friendly methodology was found to be general for the synthesis of substituted aromatic pyridyl sulfides and sulfones.

  DOI：

  10.1021/op700060e
• 作为产物：
  描述：

  2-氯喹啉 、 sodium thiophenolate 以 乙醇 为溶剂， 以89%的产率得到2-(苯基硫)喹啉
  参考文献：
  名称：

  杂芳族硫醚-有机锡烷交叉偶联。

  摘要：

  [反应：见正文]杂芳族硫醚和芳基，杂芳基和链烯基锡烷在THF中于50℃参与钯催化的铜（I）介导的交叉偶联反应。

  DOI：

  10.1021/ol0273497

文献信息

• Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists
  作者：Raimo Saari、Jonna-Carita Törmä、Tapio Nevalainen

  DOI：10.1016/j.bmc.2010.11.059

  日期：2011.1

  Quinoline, isoquinoline, quinoxaline, and quinazoline derivatives were synthesized using microwave-assisted synthesis and their CB1/CB2 receptor activities were determined using the [35S]GTPγS binding assay. Most of the prepared quinoline, isoquinoline, and quinoxalinyl phenyl amines showed low-potency partial CB2 receptor agonists activity. The most potent CB2 ligand was the 4-morpholinylmethanone

  使用微波辅助合成法合成喹啉，异喹啉，喹喔啉和喹唑啉衍生物，并使用[ 35 S]GTPγS结合测定法测定其CB1 / CB2受体活性。大部分制备的喹啉，异喹啉和喹喔啉基苯胺均显示出低效的部分CB2受体激动剂活性。最有效的CB2配体是4-吗啉基甲酮衍生物（化合物40e）（-log EC 50  = 7.8；E max  = 75％）。异喹啉-1-基（3-三氟甲基-苯基）胺（化合物26c）是一种高效的CB2激动剂（-log EC 50  = 5.8; E max = 128％）。在这些研究中，没有发现明显的CB1受体激活或失活，除了40e表现出弱的CB1激动剂活性（CB1-log EC 50  = 5.0）。这些配体用作开发选择性CB2受体激动剂的新型模板。
• Antifungal and antiparasitic indoloquinoline derivates
  申请人：Ablordeppey Y. Seth

  公开号：US20070232640A1

  公开（公告）日：2007-10-04

  A compound having the formula: wherein: R is an electron withdrawing or electron donating moiety; R 5 and R 10 may be the same or different and are a straight or branched 1-5 carbon or heteroatom chain substituted terminally by a cycloalkyl or aromatic ring, or other structural isomer or complex thereof; n is the position of substitution of R; Z is N—R 10 , O, S, S═O, CH 2 or C═O; y is 1-5 and Q is Z or NH, with the proviso that, where Z is NH, N—CH 3 , S or O and R n is H, R 5 may not be CH 3 ; as well as quaternary ammonium salts thereof and their use as pharmacological compositions and for methods of treatment.

  具有以下化学式的化合物： 其中：R是一个电子受体或电子给予基团； R5和R10可以相同也可以不同，是一条直链或支链的1-5碳或杂原子链，在末端被环烷基或芳香环取代，或其他结构异构体或其复合物；n是R的取代位置； Z是N—R10，O，S，S═O，CH2或C═O；y为1-5，Q为Z或NH， 但是，如果Z为NH，N—CH3，S或O，且Rn为H，则R5可能不是 ；以及其季铵盐和它们作为药物组合物的用途和治疗方法。
• Ring Opening of Pymisyl‐Protected Aziridines with Organocuprates
  作者：Jan Bornholdt、Jakob Felding、Rasmus P. Clausen、Jesper L. Kristensen

  DOI：10.1002/chem.201001026

  日期：2010.11.2

  The pyrimidine‐2‐sulfonyl (pymisyl) group is introduced as a new protecting group that can be used to activate aziridines towards ring opening. It is readily introduced and removed under mild conditions. Regioselective ring opening of pymisyl‐protected 2‐methyl‐aziridine with organocuprates gives the corresponding sulfonamides in high yields, and the pymisyl group can subsequently be removed upon treatment

  引入了嘧啶-2-磺酰基（嘧啶基）作为新的保护基，可用于激活氮丙啶向开环的方向移动。它很容易在温和的条件下引入和除去。嘧啶保护的2-甲基氮丙啶与有机铜的区域选择性开环可得到高产率的相应磺酰胺，随后可在用硫醇盐处理后除去嘧啶基。这种新的氮保护基团的多功能性可以通过新合成的司来吉兰（一种用于治疗帕金森氏病的单胺氧化酶-B抑制剂）的合成来说明。
• Thioetherification of Chloroheteroarenes: A Binuclear Catalyst Promotes Wide Scope and High Functional-Group Tolerance
  作者：Mélanie Platon、Novi Wijaya、Vincent Rampazzi、Luchao Cui、Yoann Rousselin、Mark Saeys、Jean-Cyrille Hierso

  DOI：10.1002/chem.201403337

  日期：2014.9.22

  constrained binuclear palladium catalyst system affords selective thioetherification of a wide range of functionalized arenethiols with chloroheteroaromatic partners with the highest turnover numbers (TONs) reported to date and tolerates a large variety of reactive functions. The scope of this system includes the coupling of thiophenols with six‐ and five‐membered 2‐chloroheteroarenes (i.e., functionalized

  受约束的双核钯催化剂体系可提供具有迄今为止报道的最高周转率（TON）的氯杂芳族伙伴的多种官能化芳硫醇的选择性硫醚化，并具有多种反应功能。该系统的范围包括将硫酚与六元和五元2-氯杂芳烃（即功能化吡啶，吡嗪，喹啉，嘧啶，呋喃和噻唑）和3-溴杂芳烃（即吡啶和呋喃）偶联。富电子的拥挤苯酚和氟化苯酚也是合适的伙伴。使用相同的催化剂体系描述了未保护的氨基-2-氯吡啶与硫酚的偶联以及合成有价值的氯硫酚的成功使用。DFT研究将这种双核钯催化剂的高性能归因于含硫醇盐的静止态稳定性下降。钯载量低至0.2mol％，这对于工业应用是重要的，并且是解决催化剂活化/失活问题的一步。
• Efficient synthesis of unsymmetrical heteroaryl thioethers and chalcogenides by alkali hydroxide-mediated S_NAr reactions of heteroaryl halides and dichalcogenides
  作者：Xiantao Ma、Quan Liu、Xiaojuan Jia、Chenliang Su、Qing Xu

  DOI：10.1039/c6ra10517c

  日期：——

  An efficient alkali hydroxide-mediated SNAr reaction of heteroaryl halides has been developed for the practical synthesis of the useful unsymmetrical heteroaryl thioethers and chalcogenides. The usually odorless, easily available, lowly toxic, and easily stored and handled diorganyl dichalcogenides can be used as safer and convenient chalcogen nucleophile precursors and diverse unsymmetrical heteroaryl

  一种有效的碱金属氢氧化物-介导的小号Ñ杂芳基卤化物的反应的Ar已经开发了用于非对称有用的杂芳基硫醚和硫属化物的实际合成。通常无味，易得，低毒，易于保存和处理的二有机基二硫代半乳糖苷可以用作安全，方便的硫属元素亲核体前体，并可以通过该方法以高到高收率获得各种不对称的杂芳基硫属元素化物。